BioMérieux’s New Automated Tests for Chikungunya Virus Diagnosis Offer Better Traceability
|
By LabMedica International staff writers Posted on 16 May 2022 |
|
Chikungunya virus (CHIKV) is transmitted to humans by certain mosquitoes. Due to the significant spread of these mosquitoes throughout the world, this infection which was originally present in only tropical regions, has now been described and can be acquired locally in many countries, including recently in temperate climates like North America and Europe. Now, new tests for the diagnosis of CHIKV infection aim to help improve access to medically important automated diagnostic tests in low- and middle-income countries.
bioMérieux (Marcy-l'Étoile, France) has launched the new CE-Marked VIDAS Anti-CHIKUNGUNYA IgM and Anti-CHIKUNGUNYA IgG automated tests intended as an aid in the diagnosis of CHIKV infection. These serological assays, as recommended by international guidelines, can detect Chikungunya infection during the acute phase and into the chronic phase. Their development has been based on methods and technologies from the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID).
Used on the VIDAS family platforms, the VIDAS Anti- CHIKUNGUNYA IgM and IgG tests provide reliable results with better traceability than existing manual methods. Their performance and accuracy allow the differentiation of this diagnosis from other similar febrile syndromes caused by infections such as dengue or malaria. Based on single-sample testing and “Load & Go” concepts, the VIDAS Anti- CHIKUNGUNYA IgM and IgG are easy to use and accessible to all laboratories. Relying on bioMérieux’s expertise in infectious diseases, these serological assays enable clear-cut results with no equivocal zone and an objective interpretation.
“This new VIDAS CHIKUNGUNYA panel complements the VIDAS DENGUE solution launched last year,” said Pierre Boulud, Chief Operating Officer, Clinical Operations, bioMérieux. “Our offer of immunoassays directed against vector-borne diseases helps improve access to medically important automated diagnostic tests in low- and middle-income countries. The large VIDAS installed base in these countries allows fast and wide availability of these tests.”
Related Links:
bioMérieux
Latest Molecular Diagnostics News
- FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling
- Microbial Saliva Test Could Help Triage Esophageal Cancer Risk
- Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing
- Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer
- Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer
- New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy
- Breast Cancer-Specific Signatures Link Genome Instability to Outcomes
- FDA-Cleared Genomic Profiling Assay Guides Treatment Selection in Solid Tumors
- ctDNA Blood Test Could Help Guide Radiotherapy in Patients with Limited Metastases
- FDA-Approved MRD Blood Test Guides Adjuvant Bladder Cancer Therapy
- Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer
- Tumor Genomic Profiling Identifies High-Risk Gallbladder Cancer
- Novel Algorithm Improves Detection of B-ALL Gene Fusions
- Rapid Multiplex PCR Test Detects 11 Gastrointestinal Pathogens from Single Sample
- Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer
- Genome Sequencing Uncovers Hidden Genetic Risks in Healthy Adults
Channels
Clinical Chemistry
view channel
New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed at an advanced stage and remains one of the most lethal solid tumors. Clinicians commonly use serum carbohydrate antigen 19-9 (CA19-9) to... Read more
Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
Psychosis commonly emerges in adolescence or early adulthood and can severely disrupt social and occupational functioning. Hallucinations, delusions, and disorganized thinking often evolve gradually, hindering... Read more
Hematology
view channel
Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Immunology
view channel
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read more
Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring
Lung transplant recipients face some of the highest rates of acute cellular rejection, and routine surveillance often relies on repeated surgical biopsies. These procedures can cause complications such... Read more
Microbiology
view channel
New AMR Assay Supports Rapid Infection Control Screening in Hospitals
As antimicrobial resistance spreads worldwide, healthcare-associated infections are placing a growing burden on hospitals, increasing the need for faster and broader diagnostic solutions.... Read more
Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Ebola is a highly... Read more
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read more
Technology
view channel
AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Fragmented digital tools can slow experiment... Read more
AI Tool Automates Validation of Laboratory Software Configuration Changes
Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. A new capability now automates... Read more
Industry
view channel
Strategic Collaboration Advances RNA Foundation Models for Precision Oncology
Bulk RNA sequencing is increasingly used to study tumor biology, but standard analyses often reduce results to gene-level summaries that miss important transcript variants and mutation patterns.... Read more
